Apogee Therapeutics, Inc. - 10-Q Filing
Apogee Therapeutics filed a Form 10-Q for the quarter ended March 31, 2025. The filing includes financial data and disclosures related to its operating segments APG333/APG273 and Zumilokibart (APG777), as well as information on research and development expenses and lease agreements.
Tickers: $APGE